Who owns ASPIRE BIOPHARMA HLDGS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Aspire Biopharma Hldgs with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Aspire Biopharma Hldgs stock

Who bought or sold ASPIRE BIOPHARMA HLDGS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 429k $57k 0% Dec 2025
 View chart
XTX Topco 266k $35k 853% Dec 2025
 View chart
Antara Capital 203k $27M 0% Dec 2025
 View chart
Virtu Financial 109k $14k 100% Dec 2025
 View chart
Verition Fund Management 97k $13k 100% Dec 2025
 View chart
P. Schoenfeld Asset Management 59k $7.7k 0% Dec 2025
 View chart
Atlantic Trust 49k $6.5k 0% Dec 2025
 View chart
Crossingbridge Advisors 24k $7.4k 0% Mar 2026
 View chart
Tower Research Capital 9.6k $1.3k -69% Dec 2025
 View chart
Hallmark Capital Management 1.0k $1.0k -98% Mar 2026
 View chart
Advisor Group Holdings 100.00 $13.000000 0% Dec 2025
 View chart

Who sold out of Aspire Biopharma Hldgs?

Fund or Company Name Date Sold Shares Held Valued At
UBS Group Dec 2025 2.5M $332k
Crewe Advisors Dec 2025 813k $107k
Jane Street Dec 2025 688k $91k
Optivise Advisory Services Dec 2025 357k $47k
Geode Capital Management Dec 2025 248k $33k
Procyon Private Wealth Partners Dec 2025 233k $31k
Resolute Advisors Dec 2025 156k $21k
Three Seasons Wealth Dec 2025 125k $17k
VR Advisory Services Dec 2025 97k $13k
EP Wealth Advisors Dec 2025 63k $8.3k
Efficient Wealth Management Dec 2025 54k $7.0k
Scientech Research Dec 2025 52k $6.8k
Periscope Capital Dec 2025 50k $6.6k
Platform Technology Partners Dec 2025 38k $5.0k
Intl Fcstone Dec 2025 15k $1.9k
Point72 Asset Management Dec 2025 14k $1.9k
Colony Sep 2025 13k $2.6k
Allred Capital Management Dec 2025 11k $1.5k
Fisher Investments Dec 2025 10k $1.3k